the data suggest that mutagenesis by this combination of drugs which is used extensively in treating hodgkin 's disease is due primarily to the mechlorethamine and that the frequency of mutation-induction may be a function of the order of administration .
C0019829
hodgkin 's disease
C0025033
mechlorethamine